Association of C-Reactive Protein with Risk of Developing Type 2 Diabetes Mellitus, and Role of Obesity and Hypertension: A Large Population-Based Korean Cohort Study

Overview

Journal Sci Rep

Specialty Science

Date 2019 Mar 16

PMID 30872696

Citations 27

Authors

Suganya Kanmani

Minji Kwon

Moon-Kyung Shin

Mi Kyung Kim

Affiliations

Soon will be listed here.

Abstract

This study was undertaken to assess the associations of C-reactive protein (CRP) with incident type-2 diabetes mellitus (T2DM) and to determine the joint effect of obesity and hypertension on them in the large-scale population-based Korean cohort of the Korean Genome and Epidemiology study (KoGES). We included 22,946 men and women from 11 rural communities at baseline (2005-2011). Epidemiological data and blood samples were collected. Incident physician-diagnosed T2DM cases (130 men and 148 women) were self-reported or based on fasting glucose ≥126 mg/dL or HbA1c level ≥6.5% during a median follow-up of 3.0 years (58,916 person-years) between 2007 and 2014. After multivariate adjustment for T2DM risk factors, the hazard ratios for developing T2DM in the highest CRP tertile (T3), compared with the lowest (T1), was 2.80 (1.73-4.52; p for trend <0.0001) in women and 1.67 (1.00-2.45; p for trend 0.02) in men. The associations between CRP and incident T2DM were more prominent among the older group (≥50 years). And CRP and its combination with obesity and hypertension were associated with increased risk of T2DM. In conclusion, we found positive associations between CRP and incident T2DM in a large population-based Korean cohort.

Citing Articles

Lymphocyte Subset Imbalance in Cardiometabolic Diseases: Are T Cells the Missing Link?.

Picone F, Giudice V, Iside C, Venturini E, Di Pietro P, Vecchione C Int J Mol Sci. 2025; 26(3).

PMID: 39940640 PMC: 11816853. DOI: 10.3390/ijms26030868.

Role of C-Reactive Protein, An Inflammatory Biomarker in The Development of Atherosclerosis and Its Treatment.

Prasad K Int J Angiol. 2024; 33(4):271-281.

PMID: 39502349 PMC: 11534478. DOI: 10.1055/s-0044-1788296.

Subphenotypes of adult-onset diabetes: Data-driven clustering in the population-based KORA cohort.

Dong Q, Xi Y, Brandmaier S, Fuchs M, Huemer M, Waldenberger M Diabetes Obes Metab. 2024; 27(1):338-347.

PMID: 39466719 PMC: 11618242. DOI: 10.1111/dom.16022.

Synergistic effect of periodontitis and C-reactive protein levels on mortality: NHANES 2001-2004.

Han M, Lee W, Ahn S, Kang M, Hwang H, Kwon S PLoS One. 2024; 19(10):e0309476.

PMID: 39453923 PMC: 11508168. DOI: 10.1371/journal.pone.0309476.

Correlation of Diabetes Related Factors with Vitamin D and Immunological Parameters in T2DM Kashmiri Population.

Tarfeen N, Ul Nisa K, Masoodi S, Bhat H, Wani S, Ganai B Indian J Clin Biochem. 2024; 39(4):586-592.

PMID: 39346716 PMC: 11436511. DOI: 10.1007/s12291-023-01144-1.

References

Han T, Sattar N, Williams K, Gonzalez-Villalpando C, Lean M, Haffner S . Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002; 25(11):2016-21. DOI: 10.2337/diacare.25.11.2016. View

Cho N . Diabetes burden and prevention in Korea and the Western Pacific Region. Diabetes Res Clin Pract. 2015; 106 Suppl 2:S282-7. DOI: 10.1016/S0168-8227(14)70730-2. View

Nishikawa T, Edelstein D, Du X, Yamagishi S, Matsumura T, Kaneda Y . Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000; 404(6779):787-90. DOI: 10.1038/35008121. View

Hu G, Jousilahti P, Tuomilehto J, Antikainen R, Sundvall J, Salomaa V . Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective finnish study. J Clin Endocrinol Metab. 2009; 94(6):2099-105. DOI: 10.1210/jc.2008-2260. View

Lee C, Adler A, Sandhu M, Sharp S, Forouhi N, Erqou S . Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia. 2009; 52(6):1040-7. DOI: 10.1007/s00125-009-1338-3. View

Ha K, Kim D . Trends in the Diabetes Epidemic in Korea. Endocrinol Metab (Seoul). 2015; 30(2):142-6. PMC: 4508257. DOI: 10.3803/EnM.2015.30.2.142. View

Snijder M, Dekker J, Visser M, Stehouwer C, Yudkin J, Bouter L . Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. Diabetes Care. 2003; 26(5):1656-7; author reply 1657-8. DOI: 10.2337/diacare.26.5.1656. View

Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K . Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care. 2005; 28(10):2497-500. DOI: 10.2337/diacare.28.10.2497. View

Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M . C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med. 2003; 163(1):93-9. DOI: 10.1001/archinte.163.1.93. View

10.

Duncan B, Schmidt M, Pankow J, Ballantyne C, Couper D, Vigo A . Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003; 52(7):1799-805. DOI: 10.2337/diabetes.52.7.1799. View

11.

Kim D . The epidemiology of diabetes in Korea. Diabetes Metab J. 2011; 35(4):303-8. PMC: 3178689. DOI: 10.4093/dmj.2011.35.4.303. View

12.

Pan A, Wang Y, Yuan J, Koh W . High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study. BMC Endocr Disord. 2017; 17(1):8. PMC: 5299777. DOI: 10.1186/s12902-017-0159-5. View

13.

Visser M, Bouter L, McQuillan G, Wener M, Harris T . Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282(22):2131-5. DOI: 10.1001/jama.282.22.2131. View

14.

Jarva H, Jokiranta T, Hellwage J, Zipfel P, Meri S . Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J Immunol. 1999; 163(7):3957-62. View

15.

Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W . Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care. 2007; 30(4):854-60. DOI: 10.2337/dc06-1693. View

16.

Fukuchi Y, Miura Y, Nabeno Y, Kato Y, Osawa T, Naito M . Immunohistochemical detection of oxidative stress biomarkers, dityrosine and N(epsilon)-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions. J Atheroscler Thromb. 2008; 15(4):185-92. DOI: 10.5551/jat.e543. View

17.

Kim Y, Han B . Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2016; 46(2):e20. PMC: 5837648. DOI: 10.1093/ije/dyv316. View

18.

Freeman D, Norrie J, Caslake M, Gaw A, Ford I, Lowe G . C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002; 51(5):1596-600. DOI: 10.2337/diabetes.51.5.1596. View

19.

Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N . Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care. 2003; 26(10):2754-7. DOI: 10.2337/diacare.26.10.2754. View

20.

Pannacciulli N, De Pergola G, Giorgino F, Giorgino R . A family history of Type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women. Diabet Med. 2002; 19(8):689-92. DOI: 10.1046/j.1464-5491.2002.00770.x. View